NeuroSense Therapeutics (NRSN) Q3 2024 Earnings
NRSN·Reported December 18, 2024·Before market open
Diluted EPS came in at $-0.11, beat the $-0.16 consensus by $0.05.
Diluted EPS
$-0.11beat by $0.05
Consensus: $-0.16
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q3 2024 Earnings FAQ
Common questions about NeuroSense Therapeutics's Q3 2024 earnings report.
NeuroSense Therapeutics (NRSN) reported Q3 2024 earnings on December 18, 2024 before market open.
NeuroSense Therapeutics reported diluted EPS of $-0.11 for Q3 2024.
EPS beat the consensus estimate of $-0.16 by $0.05.